Reply to Limitations in Study Design and Stratification in Phase II Stereotactic Radiosurgery Tr

Journal of Clinical Oncology (JCO) published a clinical update in Oncology on 20 Jan 2026. The item focuses on Reply to: “Limitations in Study Design and Stratification in Phase II Stereotactic Radiosurgery Trial for Small Cell Lung Cancer Brain Metastases,” “Radiosurgery for Small Cell Lung Cancer Brain Metastases: Comparing the JLGK0901 and BWH/DFCI Trials,” and “Expanding Indications for Stereotactic Radiosurgery in Small Cell Lung Cancer With Brain Metastases”. Review the original article for the full source wording and details.

Reply to Limitations in Study Design and Stratification in Phase II Stereotactic Radiosurgery Tr

Clinical Briefing

Clinical Editorial

Source Reference

Related by Condition/Drug

Proteomics of Cancer-Associated T Cells Reveals Candidate Regulators of T Cell Functionality

CD8+ Tissue‑Resident Memory and Bystander T Cells Predict Recurrence Risk in N0 NSCLC

Dynamic ctDNA Monitoring and mTBI Predicts Immunotherapy Response in Advanced ESCC

MYC–MIZ1 Enhancer Complexes Regulate Neuroendocrine Identity in Small Cell Lung Cancer

Challenging FDA-Approved Cancer Drug Dosages: A Patient and Research Perspective

CD39+CD103+CD8+ T cells (DP) improve neoadjuvant chemoimmunotherapy response in HNSCC